pimagedine has been researched along with Bright Disease in 2 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vlassara, H | 1 |
| Striker, LJ | 1 |
| Teichberg, S | 1 |
| Fuh, H | 1 |
| Li, YM | 1 |
| Steffes, M | 1 |
| Arai, T | 1 |
| Morimoto, K | 1 |
| Oka, M | 1 |
| Hikita, T | 1 |
| Arai, K | 1 |
| Umezawa, K | 1 |
| Nagase, M | 1 |
| Yamamoto, T | 1 |
2 other studies available for pimagedine and Bright Disease
| Article | Year |
|---|---|
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Topics: Aging; Albuminuria; Animals; Glomerulonephritis; Glycation End Products, Advanced; Guanidines; Male; | 1994 |
Aminoguanidine induces haematuria of non-glomerular origin in spontaneously hypertensive rats.
Topics: Albuminuria; Animals; Arterioles; Blood Pressure; Creatinine; Glomerulonephritis; Guanidines; Hematu | 2000 |